NCT03375307 2026-04-13
Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Genitourinary Tumors With DNA-Repair Genetic Changes
National Cancer Institute (NCI)
Phase 2 Suspended
Clinical Trials
3 trialsNCT06963346 2026-03-09
Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Suspended
NCT05643690 2024-06-06
Urine Sample Collection for Validation of the AnchorDx UriFindâ„¢ Bladder Cancer Assay
AnchorDx Medical Co. Ltd. US
Suspended